Correction of early subnormal superior hemiretinal DeltaPO(2) predicts therapeutic efficacy in experimental diabetic retinopathy. (Q43785487)
Jump to navigation
Jump to search
scientific article published in November 2001
Language | Label | Description | Also known as |
---|---|---|---|
English | Correction of early subnormal superior hemiretinal DeltaPO(2) predicts therapeutic efficacy in experimental diabetic retinopathy. |
scientific article published in November 2001 |
Statements
Correction of early subnormal superior hemiretinal DeltaPO(2) predicts therapeutic efficacy in experimental diabetic retinopathy (English)
Berkowitz BA
Ito Y
Kern TS
McDonald C
1 November 2001